166 related articles for article (PubMed ID: 29808525)
21. Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort.
Choy T; Bykerk VP; Boire G; Haraoui BP; Hitchon C; Thorne C; Keystone EC; Pope JE;
Rheumatology (Oxford); 2014 Mar; 53(3):482-90. PubMed ID: 24241035
[TBL] [Abstract][Full Text] [Related]
22. [Early referral and treatment of patients with acute arthritis. Experiences from two early arthritis clinics].
Lindegaard HM; Hørslev-Petersen K; Junker P
Ugeskr Laeger; 2005 Nov; 167(47):4458-61. PubMed ID: 16305765
[TBL] [Abstract][Full Text] [Related]
23. Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis.
Yu C; Li M; Duan X; Fang Y; Li Q; Wu R; Liu S; Wang Y; Wu Z; Shi X; Jiang Z; Wang Y; Hsieh ED; Jin S; Jiang N; Wang Q; Zhao Y; Tian X; Zeng X;
Clin Exp Rheumatol; 2018; 36(5):836-840. PubMed ID: 29600939
[TBL] [Abstract][Full Text] [Related]
24. A multicentre observational study comparing patient reported outcomes to assess reliability of swollen and tender joint assessments and response to certolizumab treatment as compared to clinician assessments in rheumatoid arthritis.
Inderjeeth CA; Inderjeeth AJ; Raymond WD
Int J Rheum Dis; 2019 Jan; 22(1):73-80. PubMed ID: 30187688
[TBL] [Abstract][Full Text] [Related]
25. Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice.
Versteeg GA; Steunebrink LMM; Vonkeman HE; Ten Klooster PM; van der Bijl AE; van de Laar MAFJ
Clin Rheumatol; 2018 May; 37(5):1189-1197. PubMed ID: 29388086
[TBL] [Abstract][Full Text] [Related]
26. Achievement of NICE quality standards for patients with new presentation of inflammatory arthritis: observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.
Ledingham JM; Snowden N; Rivett A; Galloway J; Ide Z; Firth J; MacPhie E; Kandala N; Dennison EM; Rowe I
Rheumatology (Oxford); 2017 Feb; 56(2):223-230. PubMed ID: 27694337
[TBL] [Abstract][Full Text] [Related]
27. Recently diagnosed rheumatoid arthritis patients benefit from a treat-to-target strategy: results from the DREAM registry.
Steunebrink LM; Vonkeman HE; ten Klooster PM; Hoekstra M; van Riel PL; van de Laar MA
Clin Rheumatol; 2016 Mar; 35(3):609-15. PubMed ID: 26852313
[TBL] [Abstract][Full Text] [Related]
28. Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city.
Jamal S; Alibhai SM; Badley EM; Bombardier C
J Rheumatol; 2011 Jul; 38(7):1282-8. PubMed ID: 21572157
[TBL] [Abstract][Full Text] [Related]
29. Improved early identification of arthritis: evaluating the efficacy of Early Arthritis Recognition Clinics.
van Nies JA; Brouwer E; van Gaalen FA; Allaart CF; Huizinga TW; Posthumus MD; van der Helm-van Mil AH
Ann Rheum Dis; 2013 Aug; 72(8):1295-301. PubMed ID: 22952388
[TBL] [Abstract][Full Text] [Related]
30. Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis.
Demoruelle MK; Deane KD
Curr Rheumatol Rep; 2012 Oct; 14(5):472-80. PubMed ID: 22773387
[TBL] [Abstract][Full Text] [Related]
31. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
Wechalekar MD; Lester S; Proudman SM; Cleland LG; Whittle SL; Rischmueller M; Hill CL
Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
[TBL] [Abstract][Full Text] [Related]
32. Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid Arthritis.
Rannio T; Asikainen J; Kokko A; Hannonen P; Sokka T
J Rheumatol; 2016 Apr; 43(4):699-706. PubMed ID: 26879355
[TBL] [Abstract][Full Text] [Related]
33. Delayed referral of female patients with rheumatoid arthritis.
Lard LR; Huizinga TW; Hazes JM; Vliet Vlieland TP
J Rheumatol; 2001 Oct; 28(10):2190-2. PubMed ID: 11669154
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic and therapeutic delay of rheumatoid arthritis and its relationship with health care devices in Catalonia. The AUDIT study.
Corominas H; Narváez J; Díaz-Torné C; Salvador G; Gomez-Caballero ME; de la Fuente D; Campoy E; Roig-Vilaseca D; Clavaguera T; Morlà R; Torrente-Segarra V; Arasa X; Gomez-Puerta JA; Möller I; Alegre C; Graell E; Ponce A; Lisbona MP; Pérez-Garcia C; Fíguls R; Sirvent E; Poca V; Sanmartí R
Reumatol Clin; 2016; 12(3):146-50. PubMed ID: 26362843
[TBL] [Abstract][Full Text] [Related]
35. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial.
Dale J; Stirling A; Zhang R; Purves D; Foley J; Sambrook M; Conaghan PG; van der Heijde D; McConnachie A; McInnes IB; Porter D
Ann Rheum Dis; 2016 Jun; 75(6):1043-50. PubMed ID: 27026689
[TBL] [Abstract][Full Text] [Related]
36. Differences in Predictive Factors for Sustained Clinical Remission with Abatacept Between Younger and Elderly Patients with Biologic-naive Rheumatoid Arthritis: Results from the ABROAD Study.
Sekiguchi M; Fujii T; Matsui K; Murakami K; Morita S; Ohmura K; Kawahito Y; Nishimoto N; Mimori T; Sano H;
J Rheumatol; 2016 Nov; 43(11):1974-1983. PubMed ID: 27585689
[TBL] [Abstract][Full Text] [Related]
37. A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry.
Schipper LG; Vermeer M; Kuper HH; Hoekstra MO; Haagsma CJ; Den Broeder AA; van Riel P; Fransen J; van de Laar MA
Ann Rheum Dis; 2012 Jun; 71(6):845-50. PubMed ID: 22210852
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.
van der Woude D; Young A; Jayakumar K; Mertens BJ; Toes RE; van der Heijde D; Huizinga TW; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2262-71. PubMed ID: 19644846
[TBL] [Abstract][Full Text] [Related]
39. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.
Barnabe C; Homik J; Barr SG; Martin L; Maksymowych WP
J Rheumatol; 2014 Aug; 41(8):1607-13. PubMed ID: 25028371
[TBL] [Abstract][Full Text] [Related]
40. Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial.
Smolen JS; Szumski A; Koenig AS; Jones TV; Marshall L
Arthritis Res Ther; 2018 Jan; 20(1):8. PubMed ID: 29338762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
